Show simple item record

dc.date.accessioned2018-02-21T17:45:25Z
dc.date.available2018-02-21T17:45:25Z
dc.date.issued2016-11-15
dc.identifierpat9492523
dc.identifier.urihttps://hdl.handle.net/11244/54434
dc.description.abstractBroad-based, cross-protective, O-serotype independent vaccines against Shigella and related pathogenic organisms are provided. The vaccines comprise one or more of the type III secretion (TTS) apparatus needle proteins IpaD and IpaB, and/or the IpaB cognate chaperone protein IpgC. Chimeric proteins of IpaD and IpaB, and/or IpgC are also encompassed.
dc.formatapplication/pdf
dc.format.extent61 pages
dc.languageen_US
dc.publisherU.S. Patent and Trademark Office
dc.titleBroadly Protective Shigella Vaccine Based on Type III Secretion Apparatus Proteins
dc.typetext
osu.filenamepat9492523.pdf
osu.accesstypeOpen Access
dc.type.genrePatent
dc.contributor.inventorPicking, Wendy L.
dc.contributor.inventorPicking, William D.
dc.identifier.patentID9,492,523
dc.date.filed2012-12-10
dc.contributor.assigneeBoard of Regents/Oklahoma State University and the A & M Colleges
dc.subject.cpcclassesA61K 39/0283 (20130101)
dc.subject.cpcclassesC07K 14/25 (20130101)
dc.subject.cpcclassesA61K 2039/543 (20130101)
dc.subject.cpcclassesA61K 2039/55544 (20130101)
dc.subject.cpcclassesA61K 2039/58 (20130101)
dc.subject.cpcclassesA61K 2039/54 (20130101)


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record